Lessons to be learnt from Pharma in discovering ... - Antibiotic Action

antibiotic.action.com

Lessons to be learnt from Pharma in discovering ... - Antibiotic Action

Programme

0900 REGISTRATION & COFFEE

1000 Welcome

Professor Laura Piddock, Birmingham

1010 The Faropenem ‘story’

Glenn Tillotson, Formerly of Replidyne

1030 Why have so many interesting antibacterial molecules not been

developed

Peter Appelbaum, Penn State University

1050 Discussion

Led by Tony White, Transcrip Partners

1130 Why is it so hard to develop antibacterial drugs for Gram negative

bacteria

Lynn Silver, Formerly of Merck

1150 What has happened to natural product antibacterial drug discovery

and development and why

Mike Dawson, Novacta

1210 Discussion

Led by Jared Silverman, Cubist

1250 LUNCH

1400 Is there any future for inhibitors of bacterial cell wall biosynthesis

Karen Bush, Indiana University and formerly of Squibb, Lederle/Wyeth,

Johnson & Johnson

1420 Building on hindsight - how to discover, research and develop new

drugs

Lloyd Czaplewski, Abgentis Limited

1440 Discussion

Led by Ted Bianco, The Wellcome Trust

1520 Panel Q&A

Led by Ted Bianco, The Wellcome Trust

1630 Concluding remarks

Ted Bianco, The Wellcome Trust

1640 Close

An interactive one day symposium:

Lessons to be learnt from Pharma about drug discovery

and development of new antibacterial drugs

Tuesday 21 May 2013

The Wellcome Trust, London


www.antibiotic-action.com

Informing and educating all about the need to ensure antibiotics are discovered, developed and available.

This meeting is supported by:

More magazines by this user
Similar magazines